|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
47,934,000 |
Market
Cap: |
2.09(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.56 - $49.79 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Homology Medicines is a genetic medicines company. Co.'s proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors to deliver single administration genetic medicines in vivo either through its gene therapy, Co.'s nuclease-free gene editing modality, or Co.'s gene therapy to express antibodies platform. Co.'s clinical programs include: HMI-102, an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria; as well as HMI-103, an investigational gene editing candidate in clinical development for the treatment of patients with PKU.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
608 |
22,633 |
60,507 |
Total Sell Value |
$0 |
$14,716 |
$27,256 |
$80,181 |
Total People Sold |
0 |
3 |
3 |
7 |
Total Sell Transactions |
0 |
3 |
6 |
15 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2020-02-03 |
4 |
AS |
$16.16 |
$193,866 |
D/D |
(12,000) |
0 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2020-02-03 |
4 |
OE |
$0.63 |
$7,579 |
D/D |
12,000 |
12,000 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2020-01-30 |
4 |
S |
$15.45 |
$7,879,037 |
I/I |
(509,970) |
0 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2020-01-29 |
4 |
S |
$15.45 |
$136,808 |
I/I |
(8,857) |
509,970 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2020-01-28 |
4 |
S |
$15.51 |
$1,021,936 |
I/I |
(65,891) |
518,827 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2020-01-27 |
4 |
S |
$15.77 |
$3,049,600 |
I/I |
(193,359) |
584,718 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2020-01-24 |
4 |
S |
$15.69 |
$5,965,000 |
I/I |
(380,256) |
778,077 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2020-01-02 |
4 |
AS |
$20.50 |
$122,984 |
D/D |
(6,000) |
0 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2020-01-02 |
4 |
OE |
$0.63 |
$3,790 |
D/D |
6,000 |
6,000 |
|
- |
|
Seymour Albert |
Chief Scientific Officer |
|
2020-01-02 |
4 |
AS |
$20.50 |
$187,216 |
D/D |
(9,133) |
154,017 |
|
- |
|
Tzianabos Arthur |
President & CEO |
|
2020-01-02 |
4 |
AS |
$20.50 |
$256,191 |
D/D |
(12,500) |
90,005 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2019-12-24 |
4 |
S |
$21.95 |
$7,682,535 |
I/I |
(350,000) |
1,766,106 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2019-12-23 |
4 |
S |
$21.83 |
$2,859,193 |
I/I |
(130,979) |
1,917,339 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2019-12-20 |
4 |
S |
$21.50 |
$454,278 |
I/I |
(21,129) |
1,973,934 |
|
- |
|
Deerfield Mgmt Hif, L.p. |
Possible Member of 10% Group |
|
2019-12-19 |
4 |
S |
$21.68 |
$273,589 |
I/I |
(12,622) |
1,983,064 |
|
- |
|
Seymour Albert |
Chief Scientific Officer |
|
2019-12-02 |
4 |
AS |
$16.23 |
$150,970 |
D/D |
(9,300) |
163,150 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2019-12-02 |
4 |
AS |
$16.21 |
$97,266 |
D/D |
(6,000) |
0 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2019-12-02 |
4 |
OE |
$0.64 |
$3,840 |
D/D |
6,000 |
6,000 |
|
- |
|
Tzianabos Arthur |
President & CEO |
|
2019-12-02 |
4 |
AS |
$16.25 |
$203,176 |
D/D |
(12,500) |
102,505 |
|
- |
|
Seymour Albert |
Chief Scientific Officer |
|
2019-11-29 |
4 |
AS |
$16.06 |
$149,390 |
D/D |
(9,300) |
172,450 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2019-11-29 |
4 |
AS |
$16.00 |
$96,000 |
D/D |
(6,000) |
0 |
|
- |
|
Smith W Bradford |
CFO, Treasurer & Secretary |
|
2019-11-29 |
4 |
OE |
$0.64 |
$3,840 |
D/D |
6,000 |
6,000 |
|
- |
|
Tzianabos Arthur |
President & CEO |
|
2019-11-29 |
4 |
AS |
$16.04 |
$200,559 |
D/D |
(12,500) |
115,005 |
|
- |
|
Gregory Richard J. |
Director |
|
2019-11-18 |
4 |
OE |
$0.03 |
$324 |
D/D |
10,806 |
10,806 |
|
- |
|
Seymour Albert |
Chief Scientific Officer |
|
2019-10-01 |
4 |
AS |
$17.38 |
$161,759 |
D/D |
(9,300) |
181,750 |
|
- |
|
150 Records found
|
|
Page 4 of 6 |
|
|